ALK-positive Advanced NSCLC
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08865 | Crizotinib | 1 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 | Terminated | 1 |
| DB12267 | Brigatinib | 2 | Active Not Recruiting | 1 |
| DB12267 | Brigatinib | 2 | Completed | 1 |